Credit Suisse Ag Athenex, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.12 - $0.21 $60,000 - $105,000	-500,000 Reduced 99.97%	147 $0
Q3 2022 Nov 10, 2022	SELL	$0.24 - $1.11 $89,760 - $415,140	-374,000 Reduced 42.78%	500,147 $135,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $1,546 - $3,431	-3,771 Reduced 0.43%	874,147 $358,000
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $1,641 - $3,304	-2,078 Reduced 0.24%	877,918 $728,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $372 - $805	-274 Reduced 0.03%	879,996 $1.2 Million
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $743,171 - $1.21 Million	250,226 Added 39.72%	880,270 $2.65 Million
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $466,432 - $644,958	125,723 Added 24.93%	630,044 $2.91 Million
Q1 2021 May 14, 2021	BUY	$4.08 - $14.75 $1.66 Million - $6 Million	406,795 Added 417.11%	504,321 $2.17 Million
Q4 2020 Feb 12, 2021	BUY	$11.06 - $14.01 $207,430 - $262,757	18,755 Added 23.81%	97,526 $1.08 Million
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $31,303 - $44,392	3,051 Added 4.03%	78,771 $954,000
Q2 2020 Aug 12, 2020	BUY	$7.11 - $13.76 $280,859 - $543,547	39,502 Added 109.07%	75,720 $1.04 Million
Q1 2020 May 13, 2020	SELL	$5.71 - $15.85 $60,668 - $168,406	-10,625 Reduced 22.68%	36,218 $280,000
Q4 2019 Feb 12, 2020	BUY	$9.6 - $17.75 $34,828 - $64,397	3,628 Added 8.4%	46,843 $716,000
Q3 2019 Nov 12, 2019	BUY	$12.16 - $21.0 $185,926 - $321,090	15,290 Added 54.75%	43,215 $525,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $69,818 - $146,440	7,396 Added 36.03%	27,925 $553,000
Q1 2019 May 14, 2019	SELL	$11.11 - $13.49 $25,664 - $31,161	-2,310 Reduced 10.11%	20,529 $251,000
Q4 2018 Feb 13, 2019	BUY	$10.24 - $15.49 $111,462 - $168,608	10,885 Added 91.06%	22,839 $290,000
Q3 2018 Nov 13, 2018	SELL	$15.53 - $19.97 $157,381 - $202,375	-10,134 Reduced 45.88%	11,954 $185,000
Q2 2018 Aug 14, 2018	BUY	$15.88 - $19.5 $350,757 - $430,716	22,088 New	22,088 $413,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account